Impact of the Implementation of the EAU Guidelines Recommendation on Reporting and Grading of Complications in Patients Undergoing Robot-assisted Radical Cystectomy: A Systematic Review.

Journal: European urology
Published Date:

Abstract

In 2012, the European Association of Urology (EAU) Ad Hoc Panel proposed a standardised methodology on reporting and grading complications after urological surgical procedures. The aim of the current study was to assess the impact of this implementation on complications reporting for patients undergoing robot-assisted radical cystectomy (RARC). A systematic review of all English-language original articles published on RARC until March 2020 was performed using PubMed, Scopus, and Web of Science databases. The study selection process followed the Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA) criteria. The quality of reporting and grading complication was evaluated according to the EAU recommendations. Our analysis failed to observe a statistically significant improvement in reporting outcomes after the EAU guidelines recommendations except for three of the 14 criteria proposed (ie, follow-up duration, utilisation of a severity grade system, and risk factors included in the analyses). A lower statistically significant adherence to outcome reporting in terms of inclusion of readmissions and causes (p = 0.02), was observed. PATIENT SUMMARY: In this study, we evaluated the impact of the proposed European Association of Urology (EAU) standardised reporting tool for urological complications, in patients treated with robot-assisted radical cystectomy. A low adherence to EAU guidelines recommendations for complications reporting was observed.

Authors

  • Paolo Dell'Oglio
    Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.
  • Iulia Andras
    ORSI Academy, Melle, Belgium.
  • David Ortega
    USC Institute of Urology, University of Southern California, 1441 Eastlake Ave., Suite 7416, Los Angeles, CA, 90089-9178, USA.
  • Antonio Galfano
    Department of Urology, Ospedale Niguarda Ca' Granda, Milan, Italy.
  • Walter Artibani
    Urology Clinic, A.O.U.I. Verona, Verona, Italy.
  • Riccardo Autorino
    Department of Urology, Rush University, Chicago, IL, USA.
  • Elio Mazzone
    Department of Urology, Onze Lieve Vrouw Hospital, Aalst, Belgium; ORSI Academy, Melle, Belgium.
  • Nicolae Crisan
    Department of Urology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Aldo Massimo Bocciardi
    Department of Urology, Ospedale Niguarda Ca' Granda, Milan, Italy.
  • Rafael Sanchez-Salas
    Department of Urology, Institut Mutualiste Montsouris, Paris, France.
  • Inderbir Gill
    USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Peter Wiklund
    Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
  • Mihir Desai
    Catherine and Joseph Aresty Department of Urology, USC Institute of Urology, Keck School of Medicine/Norris Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Dionysios Mitropoulos
    1st Department of Urology, University of Athens Medical School, Athens, Greece.
  • Alexandre Mottrie
    ORSI Academy Melle Belgium.
  • Giovanni E Cacciamani
    USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA - giovanni.cacciamani@med.usc.edu.